In tumors, IFNγ secreted by activated tumor-infiltrating T cells can induce the expression of the MHC-I component genes in cancer cells [28], boosting the tumor antigen presentation and enhancing the CD8+ T-cell-mediated cancer cell clearance [28,29]. The gene discussed is IFNG; the disease is cancer.